Work

A genetically engineered adenovirus vector targeted to CD40 mediates transduction of canine dendritic cells and promotes antigen-specific immune responses in vivo

Year: 2009

Type: article

Source: Vaccine

DOI: 10.1016/j.vaccine.2009.09.055

Authors: Erin E. Thacker, Masaharu Nakayama, Bruce F. Smith, R. Curtis Bird, Zhanat Muminova, Theresa V. Strong, Laura Timares, Nikolay Korokhov, Ann Marie O’Neill, Tanja D. de Gruijl, Joel N. Glasgow, Kenzaburo Tani, David T. Curiel

Institutions: Auburn University, University of Alabama at Birmingham, UAB Medicine, Amsterdam UMC Location Vrije Universiteit Amsterdam, Kyushu University, Medical Institute of Bioregulation, Kyushu University

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases

Awards: Targeted Gene Therapy for Lymphoma, Cancer Gene Therapy Training Program, UAB Skin Diseases Research Center, Training in Investigative Dermatology

OpenAlex ID: W2027040539

FWCI: 2.156

Cites: 64

Cited by: 50

Related to: 10